NASDAQ: REGN
Regeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?

Insider buying vs selling

Have Regeneron Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marion McCourtEVP2026-09-031,131$857.39
$969.71kSell
Kathryn GuariniDirector2026-09-02400$850.00
$340.00kSell
Kathryn GuariniDirector2026-09-02400$719.37
$287.75kBuy
Marion McCourtEVP2026-09-021,215$850.00
$1.03MSell
Joseph J. LarosaCLO;EVP2026-08-1912,282$381.92
$4.69MBuy
Joseph J. LarosaCLO;EVP2026-08-199,019$830.15
$7.49MSell
Christopher R. FenimoreCFO;EVP2026-08-184,599$813.47
$3.74MSell
Christopher R. FenimoreCFO;EVP2026-08-186,283$381.92
$2.40MBuy
Huda Y. ZoghbiDirector2026-08-10800$376.69
$301.35kBuy
Kathryn GuariniDirector2026-08-10400$800.00
$320.00kSell

1 of 12

REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REGN insiders and whales buy or sell their stock.

REGN Shareholders

What type of owners hold Regeneron Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sanofi35.47%36,518,618$28.66BInsider
George Yancopoulos1.39%1,429,087$1.12BInsider
P. Roy Vagelos0.91%932,432$731.82MInsider
Leonard S. Schleifer0.83%853,207$669.64MInsider
Neil Stahl0.08%84,379$66.22MInsider
William Roberts0.07%71,078$55.79MInsider
Murray A. Goldberg0.07%70,836$55.60MInsider
Plew Daniel P. Van0.07%67,324$52.84MInsider
Joseph J. Larosa0.06%58,728$46.09MInsider
Andrew J. Murphy0.05%56,498$44.34MInsider

1 of 3

REGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REGN0.09%39.28%Net SellingNet Buying
ARGX0.05%0.00%
MRNA0.08%24.05%Net BuyingNet Buying
RVMD0.10%9.00%Net SellingNet Selling
ONC0.00%30.89%Net SellingNet Selling

Regeneron Pharmaceuticals Stock Ownership FAQ

Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals (NASDAQ: REGN) is owned by 0.09% institutional shareholders, 39.28% Regeneron Pharmaceuticals insiders, and 60.63% retail investors. Sanofi is the largest individual Regeneron Pharmaceuticals shareholder, owning 36.52M shares representing 35.47% of the company. Sanofi's Regeneron Pharmaceuticals shares are currently valued at $28.66B.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.